Study status
tumor
TUMOR
From study start 24-AUG-2020 to cut-off date 01-JUL-2022, 185 pts. of 2.494 pts. evaluated at DN-MTB have been pre-screened and found potentially eligible for ProTarget (Fig. Patient enrollment status in ProTarget. The figure illustrates the number of molecular tumor profiles (Total MTB) assessed at the DN-MTB, and for ProTarget: the number of pre-screened pts. (Prescreen), number of pts. with informed consent (Consented), and number of pts. enrolled in treatment from study start 24-AUG-2020 to cut-off date 01-JUL-2022